ABACAVIR HSR OVERVIEW
The Abacavir Hypersensitivity Reaction (ABC HSR) educational programme aims to maintain low morbidity and mortality from ABC HSR in general, and to minimise the risk of ABC rechallenge in patients with clinically suspected HSR, regardless of HLA-B*5701 status.
Abacavir Hypersensitivity Reaction slides
Download the Abacavir Hypersensitivity Reaction slide deck
NP-GBL-HVX-WCNT-220048 November 2022
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221441.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
